The bio decontamination market offers several sterilization and disinfection techniques and services to eliminate harmful microorganisms such as bacteria, viruses, and spores. Hydrogen peroxide gas plasma, chlorine dioxide gas, and peracetic acid are some commonly used chemical agents in bio decontamination. These agents can thoroughly disinfect rooms and equipment within a short time frame without damaging heat-sensitive materials. Bio decontamination helps enhance patient safety, reduce healthcare costs, and minimize supply chain disruptions by removing pathogens from the hospital environment.
The Global Bio Decontamination Market is estimated to be valued at US$ 293.77 Mn in 2024 and is expected to exhibit a CAGR of 9.5% over the forecast period 2024 To 2031.
Key Takeaways
Key players operating in the bio decontamination market are STERIS Corporation, Ecolab, Inc., TOMI Environmental Solutions, Inc., JCE Biotechnology, Fedegari Autoclavi SpA, Howorth Air Technology Ltd., Noxilizer, Inc., ClorDiSys Solutions, Inc., Wales Group, and Wenzhou Weike Biological Laboratory Equipment Co., Ltd. The increasing prevalence of hospital-acquired infections and rising healthcare expenditure are fueling the demand for effective bio decontamination services and technologies. Major market players are expanding their geographical presence through mergers & acquisitions and collaboration with regional service providers to capitalize on high growth opportunities in emerging markets.
Market key trends
The use of hydrogen peroxide gas plasma for decontamination is one of the prominent trends witnessed in the bio decontamination market. Hydrogen peroxide gas plasma is an advanced non-thermal sterilization technology that uses a mixture of hydrogen peroxide and gas plasma to effectively kill microbes without harming heat-sensitive medical equipment and materials. It provides rapid, chemical-free sterilization and leaves no toxic residues. The adoption of hydrogen peroxide gas plasma Bio Decontamination Market Growth is increasing globally due to its material compatibility and ability to thoroughly disinfect healthcare facilities in a short turnaround time.
Porter’s Analysis
Threat of new entrants: High costs associated with research, infrastructure, compliance and marketing create barriers for new companies.
Bargaining power of buyers: Several significant buyers exist in the pharmaceutical and healthcare industries, giving them some bargaining power over suppliers.
Bargaining power of suppliers: A few major global players exist with necessary expertise in decontamination chambers and other technologies, giving them bargaining power over buyers.
Threat of new substitutes: No close substitute exists currently for proven bio decontamination methods needed in healthcare facilities and pharmaceutical production processes.
Competitive rivalry: Major players compete on specific technologies, brand recognition and geographic reach but the market remains quite consolidated among leading global suppliers.
Geographical regions: North America currently accounts for the largest share of the global bio decontamination market due to stringent regulatory standards and established healthcare infrastructure in countries like the US.
The Asia Pacific region is poised to become the fastest growing market for bio decontamination during the forecast period due to increasing healthcare expenditure, rising medical tourism and growing stringent regulations aimed at infection control in countries like China and India.
Get more insights on - Bio Decontamination Market
Explore More Related Article on - Epinephrine Market
For Enhanced Understanding, Dive into the Report in the Language that Connects with You.
About Author:
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163)